Your browser doesn't support javascript.
loading
Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy.
Lee, Anbok; Jo, Sunmi; Lee, Changhu; Shin, Hyun-Hee; Kim, Tae Hyun; Ahn, Ki Jung; Park, Sung-Kwang; Cho, Heunglae; Yoon, Hye-Kyoung; Kim, Woo Gyeong; Park, Jiyoung; Choi, Yunseon.
Afiliación
  • Lee A; Department of Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Jo S; Department of Radiation Oncology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Lee C; Department of Biological Sciences, School of Life Sciences, Ulsan National Institutes of Science and Technology, Ulsan, South Korea.
  • Shin HH; Department of Biological Sciences, School of Life Sciences, Ulsan National Institutes of Science and Technology, Ulsan, South Korea.
  • Kim TH; Department of Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Ahn KJ; Department of Radiation Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Park SK; Department of Radiation Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Cho H; Department of Radiation Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Yoon HK; Department of Pathology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Kim WG; Department of Pathology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Park J; Department of Biological Sciences, School of Life Sciences, Ulsan National Institutes of Science and Technology, Ulsan, South Korea. jpark@unist.ac.kr.
  • Choi Y; Department of Radiation Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. rtyoon@gmail.com.
Breast Cancer ; 26(5): 672-680, 2019 Sep.
Article en En | MEDLINE | ID: mdl-30927244

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Diabetes Mellitus Tipo 2 / Terapia Molecular Dirigida / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Diabetes Mellitus Tipo 2 / Terapia Molecular Dirigida / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur